Search alternatives:
cancer decrease » cancer disease (Expand Search), caused decreased (Expand Search)
marked decrease » marked increase (Expand Search)
cancer decrease » cancer disease (Expand Search), caused decreased (Expand Search)
marked decrease » marked increase (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients.
Published 2025“…This decrease was larger in the disconnected than in the contralateral cortex. …”
-
9
-
10
-
11
-
12
-
13
Biases in larger populations.
Published 2025“…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …”
-
14
-
15
-
16
-
17
Table 1_Pan-cancer multi-omics analysis of CCT4 in tumor progression and cancer immunity, with focus on lung adenocarcinoma.docx
Published 2025“…</p>Methods<p>To address this gap, we integrated transcriptomics, proteomics, genomics, epigenetics and immunogenomics data. A comprehensive pan-cancer analysis was conducted (including the expression patterns, clinical relevance, prognosis value, immune infiltration of pan-cancer). …”
-
18
Data Sheet 1_Pan-cancer multi-omics analysis of CCT4 in tumor progression and cancer immunity, with focus on lung adenocarcinoma.docx
Published 2025“…</p>Methods<p>To address this gap, we integrated transcriptomics, proteomics, genomics, epigenetics and immunogenomics data. A comprehensive pan-cancer analysis was conducted (including the expression patterns, clinical relevance, prognosis value, immune infiltration of pan-cancer). …”
-
19
Data Sheet 1_The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer.docx
Published 2024“…Introduction<p>Aldo-keto reductase 1B10 (AKR1B10) is a multifunctional enzyme, which is important in cancer development and progression, but the landscape of AKR1B10 in pan-cancers and in tumor microenvironment is unclear.…”
-
20
Supplementary file 2_Immune indicators as predictors of cancer-related fatigue: a risk prediction model in pan-cancer patients.docx
Published 2025“…This study aimed to identify immune and clinical factors associated with CRF in a pan-cancer cohort and to develop a predictive model for CRF to inform personalized clinical management.…”